Physical Activity Enhancing Programme in COPD

Launched by UNIVERSITY OF EDINBURGH · Jan 21, 2015

Keywords

ClinConnect Summary

Study Design:

For logistical purposes, the study is divided into two work packages (WP): 1) Pilot study of DirectLife activity monitor in the daily routine of patients with COPD (WP1), which is a cross-sectional study; 2) Physical activity enhancing programme - main project (WP2), which is a randomized controlled trial. Both studies will be performed at Leith's Community Treatment Centre (LCTC) and its satellites (Midlothian Community Hospital (Bonnyrigg) \& St Johns Hospital (Livingston) - Edinburgh). Only patients with COPD referred to pulmonary rehabilitation at LCTC and its satellites ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of COPD according to Global Initiative for Chronic Obstructive Lung Disease (GOLD, 2013) referred for pulmonary rehabilitation;
• • Clinical stability concerning pulmonary infections or acute exacerbations within last four weeks;
• • Absence of recent Myocardial Infarction (within last 3 months), unstable angina, other significant cardiac problems, SBP \> 180 mmHg, DBP \> 100 mmHg or tachycardia (higher than 100 bpm);
• • Absence of significant orthopaedic, neurological, cognitive and/or psychiatric impairment restricting mobility;
• • Not following any exercise programme in the last 6 months.
• Exclusion Criteria:
• • Orthopaedic, neurological or other complaints that significantly impair normal biomechanical movement patterns, as judged by the investigator;
• • Respiratory diseases other than COPD (e.g. asthma);
• • COPD exacerbations within 4 weeks prior to Visit 1;
• • Cognitive impairment and inability to give informed consent, as judged by the investigator;
• • Involvement in the planning and/or conduct of the study;
• • Participants should not be taking part in any other studies.